Dumont & Blake Investment Advisors’s GALENA BIOPHARMA INC COM RXII Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-39,000
| Closed | -$14K | – | 171 |
|
|
2016
Q3 | $14K | Hold |
39,000
| – | – | 0.01% | 161 |
|
|
2016
Q2 | $18K | Hold |
39,000
| – | – | 0.01% | 161 |
|
|
2016
Q1 | $53K | Buy |
39,000
+8,000
| +26% | +$10.9K | 0.03% | 148 |
|
|
2015
Q4 | $46K | Buy |
31,000
+325
| +1% | +$482 | 0.02% | 151 |
|
|
2015
Q3 | $48K | Buy |
30,675
+1,000
| +3% | +$1.57K | 0.03% | 144 |
|
|
2015
Q2 | $50K | Hold |
29,675
| – | – | 0.02% | 143 |
|
|
2015
Q1 | $41K | Hold |
29,675
| – | – | 0.02% | 144 |
|
|
2014
Q4 | $45K | Hold |
29,675
| – | – | 0.02% | 141 |
|
|
2014
Q3 | $61K | Hold |
29,675
| – | – | 0.03% | 140 |
|
|
2014
Q2 | $91K | Hold |
29,675
| – | – | 0.05% | 145 |
|
|
2014
Q1 | $74K | Buy |
29,675
+2,000
| +7% | +$4.99K | 0.04% | 141 |
|
|
2013
Q4 | $137K | Buy |
27,675
+2,575
| +10% | +$12.7K | 0.07% | 137 |
|
|
2013
Q3 | $57K | Buy |
25,100
+6,500
| +35% | +$14.8K | 0.03% | 136 |
|
|
2013
Q2 | $41K | Buy |
+18,600
| New | +$41K | 0.02% | 114 |
|